Ellagic Acid Exerts Dual Action to Curb the Pathophysiological Manifestations of Sickle Cell Disease and Attenuate the Hydroxyurea-Induced Myelosuppression in Berkeley Mice.

Gour, Abhishek; Kour, Dilpreet; Pandian, Ramajayan; Bhardwaj, Mahir; Sawant, Sanghapal D; Kumar, Ajay; Nandi, Utpal

Gour, Abhishek; Kour, Dilpreet; Pandian, Ramajayan; Bhardwaj, Mahir; Sawant, Sanghapal D; Kumar, Ajay; Nandi, Utpal.

Afiliação

Gour A; Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
Kour D; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Pandian R; Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
Bhardwaj M; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Sawant SD; Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
Kumar A; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Nandi U; Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.

ACS Pharmacol Transl Sci ; 6(6): 868-877, 2023 Jun 09.

Article em En | MEDLINE | ID: mdl-37325443

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article